Tes Pharma is a research-based biotech, founded in 2011 by Professor Roberto Pellicciari, focused on delivering proprietary first-in-class drug candidates for oncology and metabolic diseases. Tes Pharma’s fully integrated scientific team translates expertise in cellular and molecular biology, medicinal, computational and analytical chemistry in the discovery of innovative therapies. Tes Pharma has a broad portfolio of drug discovery projects based on in-house research that are unlocking the potential of novel therapeutic targets, including orphan nuclear receptors.